Unfortunately, Cardiovascular Research Foundation has limited available public data.

Create an account for free to request more data.

Cardiovascular Research Foundation Logo

MIP Score

73

Med Research
Hereditary Disease Research

Cardiovascular Research Foundation

Mission

Cardiovascular research foundation is an independent, academically focused organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. the organization has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in the subspecialty of interventional cardiology and endovascular medicine.

Basic Information

Tax-Exempt

Address

1700 Broadway, New York, New York, 10019

View all New York charities

Founded in

1991

EIN

52-1752653

Total Assets

$76.09 million

UN Sustainable Development Goals Supported

This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

Showing 1 of 1 goals

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

73

58

/100

Program Expense Ratio

86.69%

18

/20

Program Revenue Growth

37.37%

18

/20

Leverage Ratio

0.5703

8

/20

Working Capital Ratio

0.5707

8

/20

Fundraising Efficiency

5.939

6

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants7.868M12.83%
Program Services52.86M86.19%
Investment Income393K0.64%
Sales of Non-Inventory Assets262.6K0.43%
Other Notable Sources26.14K0.04%
Total Revenue61.32M100.00%